Nidan Laboratories and Healthcare (NSE:NIDAN) Long-Term Debt: ₹39.0 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NIDAN Nidan Laboratories and Healthcare Ltd NSE:NIDAN
67 GF Score
Price ₹13.35
View Full Analysis

What is Nidan Laboratories and Healthcare Long-Term Debt?

Nidan Laboratories and Healthcare NSE:NIDAN -3.61% 67 Long-Term Debt is ₹39.0 Mil as of Mar. 2025. GuruFocus rates NSE:NIDAN with a GF Score™ of 67/100.

Nidan Laboratories and Healthcare's Long-Term Debt for the quarter that ended in Mar. 2025 was ₹39.0 Mil.

Nidan Laboratories and Healthcare's quarterly Long-Term Debt declined from Mar. 2024 (₹42.9 Mil) to Sep. 2024 (₹42.7 Mil) and declined from Sep. 2024 (₹42.7 Mil) to Mar. 2025 (₹39.0 Mil).

Nidan Laboratories and Healthcare's annual Long-Term Debt declined from Mar. 2023 (₹47.7 Mil) to Mar. 2024 (₹42.9 Mil) and declined from Mar. 2024 (₹42.9 Mil) to Mar. 2025 (₹39.0 Mil).

Nidan Laboratories and Healthcare  (NSE:NIDAN) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Nidan Laboratories and Healthcare Long-Term Debt Related Terms

Nidan Laboratories and Healthcare Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Nidan Laboratories and Healthcare's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nidan Laboratories and Healthcare Long-Term Debt Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Long-Term Debt
Get a 7-Day Free Trial 141.57 94.18 47.75 42.94 38.95

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 47.75 0.00 42.94 42.66 38.95
NSE:NIDAN
67GF Score
Nidan Laboratories and Healthcare Ltd NSE:NIDAN
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹39.0 Mil mean?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a Long-Term Debt of ₹39.0 Mil as of Mar. 2025.
Is Nidan Laboratories and Healthcare's Long-Term Debt too high?
Nidan Laboratories and Healthcare's current Long-Term Debt is ₹39.0 Mil. Overall, Nidan Laboratories and Healthcare has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Nidan Laboratories and Healthcare's Long-Term Debt compare to TMO and DHR?
Nidan Laboratories and Healthcare's Long-Term Debt of ₹39.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Nidan Laboratories and Healthcare's current Long-Term Debt is ₹39.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nidan Laboratories and Healthcare stock overvalued right now?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a current Long-Term Debt of ₹39.0 Mil. The current Long-Term Debt is ₹39.0 Mil. Nidan Laboratories and Healthcare's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Nidan Laboratories and Healthcare (NSE:NIDAN), the current Long-Term Debt is ₹39.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nidan Laboratories and Healthcare Business Description

Address Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.
67GF Score

Get the complete analysis for NSE:NIDAN

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.35
Price